Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 15/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18825171 | 0.93 | DHODH (0.78) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14977153 | 0.89 | DHODH (0.68) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14977788 | 0.88 | DHODH (0.69) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14977794 | 0.86 | DHODH (0.74) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14985369 | 0.84 | DHODH (0.67) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL14977777 | 0.84 | GAA (0.73) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL18825131 | 0.83 | DHODH (1.00) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL18825168 | 0.83 | DHODH (1.00) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL18825164 | 0.83 | DHODH (1.00) | DHODHGAAKMT2ASMN1; SMN2 | |
| SCHEMBL18825169 | 0.83 | DHODH (1.00) | DHODHGAAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2925318-A1 | TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE | Calithera Biosciences Inc. (US) | 2015-10-07 | — | — | EP | disclosed |
| EP-2782570-A1 | HETEROCYCLIC INHIBITORS OF GLUTAMINASE | Calithera Biosciences Inc. (US) | 2014-10-01 | — | — | EP | disclosed |
| WO-2014089048-A1 | TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE | CALITHERA BIOSCIENCES, INC. (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2013078413-A1 | MODULATORS OF LIPID STORAGE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013078413-A1 | MODULATORS OF LIPID STORAGE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-05-30 | — | — | WO | disclosed |
| WO-2013078123-A1 | HETEROCYCLIC INHIBITORS OF GLUTAMINASE | CALITHERA BIOSCIENCES INC. (US) | 2013-05-30 | — | — | WO | disclosed |